Exclusives

Dr. Caroline Fife recently presented data from the USWR indicating that 46.8% of wounds had none to minimum levels of exudate, 46% had moderate exudate, and 7.1% had a large amount.

Microbion won the Innovation Showcase award at the AWC Summit for its development of pravibismane, the first compound in a new class of anti-infectives. Data from a 52-patient Phase 1b study in which pravibismane was used in the treatmeant of...

In its Q124 earnings presentation, Arjo noted that recruitment has been completed on its Wound Express RCT and the last patient follow up will be in June/July 2024. Publication of results is expected mid-2025 with launch in early 2025 in...

Sanara MedTech announced that it has entered into a $55 MM non-dilutive term loan agreement with CRG Servicing LLC, a healthcare focused investment fund, to support the company’s growth initiatives in 2024 and 2025.

A 42-patient CT will investigate a novel dermal substitute, NovoSorb BTM, for the treatment of full-thickness skin defects versus SoC with primary outcome of skin elasticity at 1 year post-transplantation vs normal skin. Recruitment is...

A 201-patient study evaluated the rate of wound closure and complications between incisional NPWT and SoC dressings in vascular surgery patients with infra-inguinal incisions and found that the use of NPWT increased the number of wounds...

Results of 105-patient RCT demonstrated DFUs treatment with a novel purified reconstituted bilayer membrane (Derma-Gide) healed at a higher rate versus SoC (ITT: 83% vs 45%) and was an effective treatment option with no adverse events. IWJ

This study examines the biomechanical effectiveness of ALLEVYN Life multilayer dressing in preventing heel ulcers. Results show that the dressing absorbs approximately 30%-45% of the mechanical energy, thereby reducing the risk of heel...